{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:25:23Z","timestamp":1771467923655,"version":"3.50.1"},"reference-count":33,"publisher":"Ubiquity Press, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.5334\/aogh.2763","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T09:33:21Z","timestamp":1586165601000},"page":"36","source":"Crossref","is-referenced-by-count":11,"title":["Unblocking Barriers of Access to Hepatitis C Treatment in China: Lessons Learned from Tianjin"],"prefix":"10.5334","volume":"86","author":[{"given":"Peiwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjia","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weishen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongdan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3285","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"key20200406053315_B1","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. Geneva: WHO; 2016. http:\/\/apps.who.int\/iris\/bitstream\/10665\/246177\/1\/WHO-HIV-2016.06-eng.pdf [Accessed 8 February 2020]."},{"key":"key20200406053315_B2","unstructured":"World Health Organization. Regional action plan for viral hepatitis in the Western Pacific 2016\u20132020. Manila: World Health Organization regional office for the Western Pacific; 2016. https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/13141\/97892906177617_eng.pdf [Accessed 8 February 2020]."},{"key":"key20200406053315_B3","unstructured":"World Health Organization. Hepatitis data and statistics in the Western Pacific. Epidemiological estimates for viral hepatitis in the Western Pacific. https:\/\/www.who.int\/westernpacific\/health-topics\/hepatitis\/regional-hepatitis-data [Accessed 8 February 2020]."},{"key":"key20200406053315_B4","unstructured":"World Health Organization. Work conducted by the London School of Hygiene & Tropical Medicine. 2 December 2016. http:\/\/whohbsagdashboard.com\/#global-strategies [Accessed 8 February 2020]."},{"key":"key20200406053315_B5","first-page":"906","article-title":"The guideline of prevention and treatment for hepatitis C: A 2015 update","volume":"23","author":"Chinese Society of Liver Diseases and Chinese Society of Infectious Diseases, Chinese Medical Association","year":"2015","journal-title":"Chinese Journal of Hepatology"},{"key":"key20200406053315_B6","unstructured":"National Health Commission. Bureau of Disease Control. Prevention and control of communicable diseases. http:\/\/www.nhc.gov.cn\/jkj\/s3578\/201904\/050427ff32704a5db64f4ae1f6d57c6c.shtml [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1056\/NEJMp1813728","article-title":"Universal medicine access through lump-sum remuneration \u2014 Australia\u2019s approach to hepatitis C","volume":"380","year":"2019","journal-title":"N Engl J Med"},{"key":"key20200406053315_B8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJMp1812959","article-title":"Brazil\u2019s fight against hepatitis C \u2014 Universalism, local production, and patents","volume":"380","year":"2019","journal-title":"N Engl J Med"},{"key":"key20200406053315_B9","unstructured":"National Health Commission. National viral hepatitis prevention and control (2017\u20132020). http:\/\/www.nhc.gov.cn\/ewebeditor\/uploadfile\/2017\/11\/20171113134002475.pdf [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B10","unstructured":"National Health Commission. National diagnosis standard for hepatitis C. http:\/\/www.nhc.gov.cn\/ewebeditor\/uploadfile\/2018\/03\/20180330092842208.pdf [accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B11","unstructured":"National Medical Products Administration. Database search. http:\/\/app1.sfda.gov.cn\/datasearchcnda\/face3\/dir.html?type=yp [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B12","volume-title":"Current situation of hepatitis C and prevention & treatment strategies in China","year":"2017"},{"key":"key20200406053315_B13","unstructured":"National Health Commission. The announcement of issuing the 2018 National Essential Medicines. Document No. 31 of 2018. http:\/\/www.nhc.gov.cn\/yaozs\/s7656\/201810\/c18533e22a3940d08d996b588d941631.shtml [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B14","unstructured":"Zhejiang Province Human Resource and Social Security Department. The announcement of including 28 medicines into the health insurance reimbursement list. (ZJSP13-2018-0001) http:\/\/www.zjhrss.gov.cn\/art\/2018\/1\/16\/art_1443137_9238.html [Accessed 8 February 2020] (in Chinses)."},{"key":"key20200406053315_B15","unstructured":"Tianjin Statistics Bureau. Population. http:\/\/stats.tj.gov.cn\/Category_1\/Index.aspx [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B16","first-page":"86","article-title":"Investigation on hepatitis C virus infection and hepatitis C virus infection in Tianjin residents","volume":"22","year":"2015","journal-title":"Shandong Medicine"},{"issue":"9","key":"key20200406053315_B17","first-page":"941","article-title":"Mortality and epidemiological characteristics of hepatocellular carcinoma associated with hepatitis B and C virus in Tianjin","volume":"32","year":"2016","journal-title":"Journal of Preventive Medicine Information"},{"key":"key20200406053315_B18","first-page":"647","article-title":"Prevalence of hepatitis C in Tianjin, China and related risk factors","volume":"4","year":"2016","journal-title":"Chinese Journal of Hepatology"},{"key":"key20200406053315_B19","unstructured":"Tianjin Center for Disease Prevention and Control. Reporting system of notifiable communicable diseases. http:\/\/www.cdctj.com.cn\/system\/2016\/02\/18\/013082454.shtml [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B20","unstructured":"The Data Center of China Public Health Science. Communicable diseases. Hepatitis. http:\/\/www.phsciencedata.cn\/Share\/ky_sjml.jsp?id=8defcfc2-b9a4-4225-b92c-ebb002321cea [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B21","unstructured":"Tianjin Municipal Human Resources and Social Security Bureau. The announcement of implementing a capitated provider payment pilot for outpatient care of hepatitis C of Tianjin basic health insurance. Document No.74 of 2018. http:\/\/hrss.tj.gov.cn\/ecdomain\/framework\/tj\/gnnknhmjegifbbodkjajlpafcampibii\/innplgdkegifbbodkjajlpafcampibii.do?isfloat=1&fileid=20180328130120135&moduleIDPage=innplgdkegifbbodkjajlpafcampibii&siteIDPage=tj&pageID=gnnknhmjegifbbodkjajlpafcampibii [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B22","unstructured":"Tianjin Municipal Human Resources and Social Security Bureau. Premium and benefit package of rural residents. Document No 41 of 2013. http:\/\/hrss.tj.gov.cn\/ecdomain\/framework\/tj\/ckoocoapccolbbogkjpnifpkdgnfeahc\/clbhpndaccolbbogkjpnifpkdgnfeahc.do?isfloat=1&fileid=20130428083007295&moduleIDPage=clbhpndaccolbbogkjpnifpkdgnfeahc&siteIDPage=tj&pageID=ckoocoapccolbbogkjpnifpkdgnfeahc [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B23","unstructured":"Tianjin Municipal Human Resources and Social Security Bureau. Subsidy to catastrophic medical expenses. Document No 321 of 2001. http:\/\/hrss.tj.gov.cn\/ecdomain\/framework\/tj\/ckoocoapccolbbogkjpnifpkdgnfeahc\/clbhpndaccolbbogkjpnifpkdgnfeahc.do?isfloat=1&fileid=20081114155807953&moduleIDPage=clbhpndaccolbbogkjpnifpkdgnfeahc&siteIDPage=tj&pageID=ckoocoapccolbbogkjpnifpkdgnfeahc [Accessed 8 February 2020] (in Chinese)."},{"issue":"03","key":"key20200406053315_B24","first-page":"30","article-title":"Chronic hepatitis C treatment cost is reduced in Tianjin","volume":"9","year":"2014","journal-title":"Tianjin Social Insurance"},{"key":"key20200406053315_B25","first-page":"48","article-title":"Comparison of capitated and fee-for-service payment methods for chronic hepatitis C","volume":"12","year":"2017","journal-title":"Tianjin Social Insurance"},{"key":"key20200406053315_B26","first-page":"59","article-title":"Expenditure and payment method study of hepatitis C treatment","volume":"10","year":"2017","journal-title":"China Health Insurance"},{"key":"key20200406053315_B27","first-page":"551","article-title":"Hepatitis C treatment guideline","volume":"43","author":"Chinese Society of Liver Diseases, Chinese Medical Association","year":"2004","journal-title":"Chinese Journal of Internal Medicine"},{"key":"key20200406053315_B28","unstructured":"Finalizada a compra de los medicamentos para hepatitis C en Brasil. 17 de enero de 2019. http:\/\/www.hepato.com\/es\/2019\/01\/finalizada-compra-dos-medicamentos-para-hepatite-c\/ [Accessed 8 February 2020] (in Portuguese)."},{"key":"key20200406053315_B29","volume-title":"China health account report","year":"2017"},{"key":"key20200406053315_B30","unstructured":"Chen J. Study on the epidemic analysis and report quality of hepatitis C in Tianjin. Tianjin Medical University. Master Dissertation 2016 (in Chinese)."},{"key":"key20200406053315_B31","volume-title":"Progress report on access to hepatitis C treatment: focus on overcoming barriers in low- and middle-income countries (WHO\/CDS\/HIV\/18.4)","author":"World Health Organization","year":"2018"},{"key":"key20200406053315_B32","unstructured":"China Daily USA. China Society. Cancer patients look to India for lifesaving drugs. (2015-01-28). http:\/\/usa.chinadaily.com.cn\/china\/2015-01\/28\/content_19426279.htm [Accessed 8 February 2020] (in Chinese)."},{"key":"key20200406053315_B33","first-page":"30","article-title":"Dying to survive and cancer care in China. Available online 3 January 2019","volume":"20","year":"2019","journal-title":"The Lancet Oncology"}],"container-title":["Annals of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/doi.org\/10.5334\/aogh.2763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:06:30Z","timestamp":1657530390000},"score":1,"resource":{"primary":{"URL":"https:\/\/annalsofglobalhealth.org\/article\/10.29024\/aogh.2763\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,2]]}},"URL":"https:\/\/doi.org\/10.5334\/aogh.2763","relation":{},"ISSN":["2214-9996"],"issn-type":[{"value":"2214-9996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]}}}